Potential Pricing for Remdesivir The FDA has approved Remdesivir for emergency use and Gilead Science will denote its current 1.5 million vials, which could potentially treat 300 thousand patients as it takes 5 to 10 treatments per patient. The WHO wants more Remdesivir: The World Health Organization said Monday that it will speak with the U.S. government […]
It looks like many states are preparing to end stay at home quarantine. If you look at the numerous charts around on the number of new coronavirus-19 cases reported each day it looks encouraging. They show a peaking and a very slow decline or at best a plateau. However, this plateau is the product of […]
A note about the weekly and monthly economic data For the past month or so, with the exception of the weekly catastrophe of new jobless claims it hasn’t been very important to keep track of the economic data. Now that it is May, that will start to change with the weekly data as of next […]
by Joseph Joyce Is There a Future for FDI? Among the economic consequences of the coronavirus pandemic will be a drop in foreign direct investment activity. The latest issue of the OECD’s FDI In Figures forecasts a decline of more than 30% in 2020 in FDI flows, even under an optimistic scenario of a recovery in the […]
Coronavirus dashboard for May 4: new infections, deaths continue slow decline Here is the update through yesterday (May 3). As usual, significant developments are in italics. The bottom line is the same as several days ago: trends in new infections, deaths, and in testing have all turned positive – if not positive enough. But the good […]
SCOTUS decided 8-1 in favor of health insurance companies and coops in MAINE COMMUNITY HEALTH OPTIONS v. UNITED STATES decision, April 27, 2020 to be paid. I have been following this issue since 2015 and SCOTUS finally ruled on Republican’s (Sessions, Upton, Kingston) blockage of the Risk Corridor Program funding. A bit of history to […]
Here Trisha Greenhalgh, an actual expert, writes what I have been trying to write. In a Twitter thread. Please click the link. Two key tweets But the principle of waiting for the definitive RCT [randomized controlled Trial] before taking action should not be seen as inviolable, or as always defining good science. On the contrary, […]
Coronavirus dashboard for May 2: good news, but still primarily due to NY Here is the update through yesterday (May 1). As usual, significant developments are in italics. The trends in new infections, deaths, and in testing have all turned positive – if not positive enough. But the good news remains primarily a NY story. I […]
On April 20th Georgia Governor Kemp called for “reopening more of the state’s economy to minimize the ‘terrible impact of Covid-19 on public health and the pocketbook.’” It would apply to certain non-essential businesses. Kemp, who was later told by Trump it was too early to reopen Georgia’s economy, was following Trump’s lead to begin […]
Arnold Kling writes (my bold): Yesterday’s post on lockdown socialism was unusual for me, in that it was not aimed at persuading someone who might disagree. Let me approach the topic by trying to make the best case for the other side. If I were a lockdown socialist, I would argue as follows. We want […]